110 results
8-K
EX-99.1
TRVN
Trevena Inc
28 Dec 23
Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise
2:09pm
to other Permitted Financing, as such term is defined in the royalty-based loan agreement with R-Bridge Healthcare Investment Advisory, Ltd. (the “Loan
8-K
EX-99.2
TRVN
Trevena Inc
28 Dec 23
Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise
2:09pm
Financing, as such term is defined in the royalty-based loan agreement with R-Bridge Healthcare Investment Advisory, Ltd. (the “Loan Agreement”), may
8-K
EX-99.1
k8bwp3nsq21aaw
14 Nov 23
Trevena Reports Third Quarter 2023 Results and Provides Business Update
12:00am
8-K
EX-99.1
rk246n9a pa0o3drds3y
2 Oct 23
Regulation FD Disclosure
7:05am
8-K
EX-99.1
j7l8bk vpehj
6 Sep 23
Regulation FD Disclosure
7:02am
8-K
EX-99.4
f45khqxw el9ix1pl
6 Sep 23
Regulation FD Disclosure
7:02am
8-K
EX-99.1
g1cxy jpl
26 Jun 23
Trevena Announces New Topline OLINVYK Data Highlighting
7:05am
8-K
EX-99.1
fqoqrft2m3fu1
15 May 23
Trevena Reports First Quarter 2023 Results and Provides Business Update
7:05am
8-K
EX-99.2
yuggx919jpbeb6
15 May 23
Trevena Reports First Quarter 2023 Results and Provides Business Update
7:05am
8-K
kuly59 uc39hyv7dru7
9 May 23
Results of Operations and Financial Condition
7:10am
8-K
EX-99.1
r1gj1
8 May 23
Trevena Announces Approval of OLINVYK in China
12:01pm
8-K
EX-99.1
qx21 g0ce
30 Mar 23
Trevena Announces Initial Topline OLINVYK Data from
7:08am
8-K
EX-99.1
0bnh90jcly
30 Mar 23
Trevena Reports Fourth Quarter 2022 Results and Provides Business Update
7:06am
8-K
EX-99.2
azrmb83v1
30 Mar 23
Trevena Reports Fourth Quarter 2022 Results and Provides Business Update
7:06am